Amgen Inc.: operating_income
| Value | {"amount": 7258000000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Amgen Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:29:19.522005+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/074bb9e3-c66c-4109-b729-3e52eb6edd18
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000318154-25-000010Retrieved: 2026-08-19T07:29:19.522005+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000318154/operating-income/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/074bb9e3-c66c-4109-b729-3e52eb6edd18
History
- no predecessors — first report